Lack of Progress in Early Diagnosis of Bladder Cancer

Urology

Volumn 69, Issue 2, 2007, Pages 270-274

  Araki, Motoo ^a   Nieder, Alan M ^a   Manoharan, Murugesan ^a   Yang, Yulong ^a   Soloway, Mark S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; AWARENESS; BLADDER CANCER; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; FEMALE; GLEASON SCORE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATECTOMY; RISK FACTOR; TREATMENT INDICATION; TUMOR VOLUME; VALIDATION PROCESS;

AGED; BIOPSY, NEEDLE; COHORT STUDIES; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; NEEDS ASSESSMENT; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 33847055912     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.10.016     Document Type: Article

References (30)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Han M., Partin A.W., Zahurak M., et al. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169 (2003) 517-523
3. Walsh P.C. Anatomic radical prostatectomy: evolution of the surgical technique. J Urol 160 (1998) 2418-2424
4. Hankey B.F., Feuer E.J., Clegg L.X., et al. Cancer surveillance series: interpreting trends in prostate cancer-part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 91 (1999) 1017-1024
5. Jhaveri F.M., Klein E.A., Kupelian P.A., et al. Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. J Clin Oncol 17 (1999) 3167-3172
6. Han M., Partin A.W., Piantadosi S., et al. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol 166 (2001) 416-419
7. D'Amico A.V., Chen M.H., Oh-Ung J., et al. Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era. Int J Radiat Oncol Biol Phys 54 (2002) 436-441
8. Halling K.C., King W., Sokolova I.A., et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 164 (2000) 1768-1775
9. Garcia Penalver C., Perez Barrios A., and Leiva Galvis O. [Clinical usefulness of the ImmunoCyt urinary test in the follow-up protocol of patients with urothelial neoplasms]. Acta Urol Esp 29 (2005) 535-541
10. Badalament R.A., Kimmel M., Gay H., et al. The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma. Cancer 59 (1987) 2078-2085
11. Schroeder G.L., Lorenzo-Gomez M.F., Hautmann S.H., et al. A side by side comparison of cytology and biomarkers for bladder cancer detection. J Urol 172 (2004) 1123-1126
12. Planz B., Synek C., Deix T., et al. Diagnosis of bladder cancer with urinary cytology, immunocytology and DNA-image-cytometry. Anal Cell Pathol 22 (2001) 103-109
13. Toma M.I., Friedrich M.G., Hautmann S.H., et al. Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer. World J Urol 22 (2004) 145-149
14. Tetu B., Tiguert R., Harel F., et al. ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma. Mod Pathol 18 (2005) 83-89
15. Chang Y.H., Wu C.H., Lee Y.L., et al. Evaluation of nuclear matrix protein-22 as a clinical diagnostic marker for bladder cancer. Urology 64 (2004) 687-692
16. Sarosdy M.F., Schellhammer P., Bokinsky G., et al. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol 168 (2002) 1950-1954
17. Mian C., Lodde M., Comploj E., et al. Liquid-based cytology as a tool for the performance of uCyt+ and Urovysion Multicolour-FISH in the detection of urothelial carcinoma. Cytopathology 14 (2003) 338-342
18. Soloway M.S. Do we have a prostate specific antigen for bladder cancer?. J Urol 161 (1999) 447-448
19. Liedberg F., Anderson H., Mansson A., et al. Diagnostic delay and prognosis in invasive bladder cancer. Scand J Urol Nephrol 37 (2003) 396-400
20. Mommsen S., Aagaard J., and Sell A. Presenting symptoms, treatment delay and survival in bladder cancer. Scand J Urol Nephrol 17 (1983) 163-167
21. Freeman J.A., Esrig D., Stein J.P., et al. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 76 (1995) 833-839
22. Amling C.L., Thrasher J.B., Frazier H.A., et al. Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol 151 (1994) 31-36
23. Nieder A.M., Brausi M., Lamm D., et al. for the International Consensus Panel: Management of stage T1 tumors of the bladder. Urology 66 (2005) 108-125
24. Kaye K.W., and Lange P.H. Mode of presentation of invasive bladder cancer: reassessment of the problem. J Urol 128 (1982) 31-33
25. Hopkins S.C., Ford K.S., and Soloway M.S. Invasive bladder cancer: support for screening. J Urol 130 (1983) 61-64
26. Sell A., Jakobsen A., Nerstrom B., et al. for the Danish Vesical Cancer Group: Treatment of advanced bladder cancer category T2, T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Scand J Urol Nephrol Suppl 138 (1991) 193-201
27. Prout Jr. G.R., Griffin P.P., and Shipley W.U. Bladder carcinoma as a systemic disease. Cancer 43 (1979) 2532-2539
28. Clavel J., Cordier S., Boccon-Gibod L., et al. Tobacco and bladder cancer in males: increased risk for inhalers and smokers of black tobacco. Int J Cancer 44 (1989) 605-610
29. Vineis P., Esteve J., Hartge P., et al. Effects of timing and type of tobacco in cigarette-induced bladder cancer. Cancer Res 48 (1988) 3849-3852
30. Lamm D.L. Bladder cancer: twenty years of progress and the challenges that remain. CA Cancer J Clin 48 (1998) 263-268